{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-1975-N-0012\" and posted_year = 2009 sorted by posted_date descending", "rows": [["FDA-1975-N-0012-0025", "FDA", "FDA-1975-N-0012", "Tab E - \"Alcavis International, Inc., Letter to FDA, March 18, 2003\" - [Alcavis, International, Inc., (Buchanan Ingerson and Rooney PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T20:35:48Z", null, 0, 0, "0900006480a4d2b1"], ["FDA-1975-N-0012-0033", "FDA", "FDA-1975-N-0012", "Tab M - \"Alcavis International, Inc. (Alston & Bird, LLP) Letter to FDA, October 4, 2006\" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T20:57:54Z", null, 0, 0, "0900006480a4d4e9"], ["FDA-1975-N-0012-0029", "FDA", "FDA-1975-N-0012", "Tab I - \"Alcavis International, Inc. Letter to FDA, July 1, 2003\" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T20:51:54Z", null, 0, 0, "0900006480a4d497"], ["FDA-1975-N-0012-0028", "FDA", "FDA-1975-N-0012", "Tab H - \"Alcavis International, Inc. Letter to FDA, June 17, 2003\" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T20:50:56Z", null, 0, 0, "0900006480a4d459"], ["FDA-1975-N-0012-0027", "FDA", "FDA-1975-N-0012", "Tab G - \"Alcavis International, Inc. Letter to FDA, June 5, 2003\" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T20:50:16Z", null, 0, 0, "0900006480a4d355"], ["FDA-1975-N-0012-0024", "FDA", "FDA-1975-N-0012", "Tab D - \"Alcavis International, Inc., Letter to FDA, December 20, 2002\" - [Alcavis, International, Inc., (Buchanan Ingerson and Rooney PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T20:34:25Z", null, 0, 0, "0900006480a4d2af"], ["FDA-1975-N-0012-0036", "FDA", "FDA-1975-N-0012", "Index of Select Scientific References Cited - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing]  re FDA-1975-N-0013-0018", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-10-27T17:29:30Z", null, 0, 0, "0900006480a6f8fa"], ["FDA-1975-N-0012-0034", "FDA", "FDA-1975-N-0012", "Tab N - \"Alcavis International, Inc. (Alston & Bird, LLP) Supplement, February 6, 2009\" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T21:00:16Z", null, 0, 0, "0900006480a4d7b5"], ["FDA-1975-N-0012-0021", "FDA", "FDA-1975-N-0012", "Tab A - Citizen Petition Filed by Robert G. Pinco, Akin, Gump, Strauss, Hauer & Feld, January 29, 1999 - (Alcavis, International, Inc., (Buchanan Ingerson and Rooney PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T20:31:45Z", null, 0, 0, "0900006480a4d24e"], ["FDA-1975-N-0012-0023", "FDA", "FDA-1975-N-0012", "Tab C - \"FDA Response to Alcavis International, Inc., November 14, 2002\" - [Alcavis, International, Inc., (Buchanan Ingerson and Rooney PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T20:33:42Z", null, 0, 0, "0900006480a4d2ac"], ["FDA-1975-N-0012-0035", "FDA", "FDA-1975-N-0012", "Tab O - \"FDA/CDER Response to Alcavis International, Inc. - Petition Denial, April 24, 2009\" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T21:01:01Z", null, 0, 0, "0900006480a4d7b6"], ["FDA-1975-N-0012-0022", "FDA", "FDA-1975-N-0012", "Tab B - \"Citizen Petition Filed by Alcavis, International, Inc., Feburary 20, 2002\" - [Alcavis, International, Inc., (Buchanan Ingerson and Rooney PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T20:32:56Z", null, 0, 0, "0900006480a4d252"], ["FDA-1975-N-0012-0026", "FDA", "FDA-1975-N-0012", "Tab F - \"68 Federal Register 32003 Dated May 29, 2003\" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T20:38:00Z", null, 0, 0, "0900006480a4d350"], ["FDA-1975-N-0012-0031", "FDA", "FDA-1975-N-0012", "Tab K - \"Alcavis International, Inc. Letter to FDA, March 15, 2004\" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T20:55:21Z", null, 0, 0, "0900006480a4d4e6"], ["FDA-1975-N-0012-0030", "FDA", "FDA-1975-N-0012", "Tab J - \"Alcavis International, Inc. Letter to FDA, February 10, 2004\" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T20:52:26Z", null, 0, 0, "0900006480a4d4e4"], ["FDA-1975-N-0012-0032", "FDA", "FDA-1975-N-0012", "Tab L - \"Alcavis International, Inc. (Alston & Bird, LLP) Letter to FDA, July 15, 2005\" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T20:56:35Z", null, 0, 0, "0900006480a4d4e7"], ["FDA-1975-N-0012-0020", "FDA", "FDA-1975-N-0012", "See FDA-1975-N-0012-0019", "Supporting & Related Material", "Background Material", "2009-10-26T04:00:00Z", 2009, 10, null, null, "2014-01-05T03:25:07Z", null, 0, 0, "0900006480a4c2d3"], ["FDA-1975-N-0012-0019", "FDA", "FDA-1975-N-0012", "Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Health-Care Antiseptic Drug Products; Reopening of the Administrative Record", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2009-10-26T04:00:00Z", 2009, 10, "2003-05-29T04:00:00Z", "2003-08-28T03:59:59Z", "2017-11-28T15:24:53Z", "03-13317", 0, 0, "09000064805c1b5f"], ["FDA-1975-N-0012-0018", "FDA", "FDA-1975-N-0012", "Petition Denial Response Letter from FDA to Alcavis International", "Other", "Denial of Petition", "2009-04-24T04:00:00Z", 2009, 4, "2009-04-24T04:00:00Z", "2019-04-04T03:59:59Z", "2018-04-03T19:26:43Z", null, 0, 0, "09000064809693f7"], ["FDA-1975-N-0012-0017", "FDA", "FDA-1975-N-0012", "Letter from Alcavis International Inc. (Alston & Bird, LLP)  to FDA - July 15, 2005", "Other", "Letter(s)", "2009-03-04T05:00:00Z", 2009, 3, "2009-03-04T05:00:00Z", null, "2017-10-27T19:14:39Z", null, 0, 0, "09000064808ea11c"], ["FDA-1975-N-0012-0016", "FDA", "FDA-1975-N-0012", "Letter from Alcavis International Inc. (Buchanan Ingersoll) to FDA - February 10, 2004", "Other", "Letter(s)", "2009-03-04T05:00:00Z", 2009, 3, "2009-03-04T05:00:00Z", null, "2017-10-27T19:13:26Z", null, 0, 0, "09000064808ea0a0"], ["FDA-1975-N-0012-0015", "FDA", "FDA-1975-N-0012", "Alcavis HDC, LLC (Alston & Bird, LLP) - Supplement re CP13", "Other", "Supplement (SUP)", "2009-02-10T05:00:00Z", 2009, 2, "2009-02-10T05:00:00Z", null, "2014-01-05T03:25:07Z", null, 0, 0, "090000648084a308"]], "truncated": false, "filtered_table_rows_count": 22, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-1975-N-0012", "p1": "2009"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009", "results": [{"value": "FDA", "label": "FDA", "count": 22, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 17, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009", "results": [{"value": 2009, "label": 2009, "count": 22, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1975-N-0012", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009&_facet=comment_start_date"}, {"name": "last_modified", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009&_facet=last_modified"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1975-N-0012&posted_year=2009&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 689.9163878988475, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}